Literature DB >> 22101487

DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes.

Subhajyoti De1, Franziska Michor.   

Abstract

Somatic copy-number alterations (SCNA) are a hallmark of many cancer types, but the mechanistic basis underlying their genome-wide patterns remains incompletely understood. Here we integrate data on DNA replication timing, long-range interactions between genomic material, and 331,724 SCNAs from 2,792 cancer samples classified into 26 cancer types. We report that genomic regions of similar replication timing are clustered spatially in the nucleus, that the two boundaries of SCNAs tend to be found in such regions, and that regions replicated early and late display distinct patterns of frequencies of SCNA boundaries, SCNA size and a preference for deletions over insertions. We show that long-range interaction and replication timing data alone can identify a significant proportion of SCNAs in an independent test data set. We propose a model for the generation of SCNAs in cancer, suggesting that data on spatial proximity of regions replicating at the same time can be used to predict the mutational landscapes of cancer genomes.

Entities:  

Mesh:

Year:  2011        PMID: 22101487      PMCID: PMC3923360          DOI: 10.1038/nbt.2030

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  30 in total

Review 1.  DNA replication in eukaryotic cells.

Authors:  Stephen P Bell; Anindya Dutta
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins.

Authors:  Michael Lisby; Jacqueline H Barlow; Rebecca C Burgess; Rodney Rothstein
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

Review 3.  Genome organization influences partner selection for chromosomal rearrangements.

Authors:  Patrick J Wijchers; Wouter de Laat
Journal:  Trends Genet       Date:  2010-12-07       Impact factor: 11.639

4.  DNA secondary structures and epigenetic determinants of cancer genome evolution.

Authors:  Subhajyoti De; Franziska Michor
Journal:  Nat Struct Mol Biol       Date:  2011-07-03       Impact factor: 15.369

Review 5.  Advances in understanding cancer genomes through second-generation sequencing.

Authors:  Matthew Meyerson; Stacey Gabriel; Gad Getz
Journal:  Nat Rev Genet       Date:  2010-10       Impact factor: 53.242

6.  Chromosome-wide assessment of replication timing for human chromosomes 11q and 21q: disease-related genes in timing-switch regions.

Authors:  Yoshihisa Watanabe; Asao Fujiyama; Yuta Ichiba; Masahira Hattori; Tetsushi Yada; Yoshiyuki Sakaki; Toshimichi Ikemura
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

Review 7.  Challenges of sequencing human genomes.

Authors:  Daniel C Koboldt; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Brief Bioinform       Date:  2010-06-02       Impact factor: 11.622

8.  Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA.

Authors:  Shiwei Song; Linda J Wheeler; Christopher K Mathews
Journal:  J Biol Chem       Date:  2003-09-17       Impact factor: 5.157

Review 9.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

10.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

View more
  92 in total

1.  Genomic rearrangement in three dimensions.

Authors:  P J Hastings; Susan M Rosenberg
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  Genomic instability: close-up on cancer copy number alterations.

Authors:  Darren J Burgess
Journal:  Nat Rev Genet       Date:  2011-11-29       Impact factor: 53.242

3.  The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.

Authors:  Junjie Lu; Hu Li; Ming Hu; Takayo Sasaki; Anna Baccei; David M Gilbert; Jun S Liu; James J Collins; Paul H Lerou
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

4.  The dilemma of choosing the ideal permutation strategy while estimating statistical significance of genome-wide enrichment.

Authors:  Subhajyoti De; Brent S Pedersen; Katerina Kechris
Journal:  Brief Bioinform       Date:  2013-08-16       Impact factor: 11.622

5.  DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes.

Authors:  Yong H Woo; Wen-Hsiung Li
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

6.  e-Driver: a novel method to identify protein regions driving cancer.

Authors:  Eduard Porta-Pardo; Adam Godzik
Journal:  Bioinformatics       Date:  2014-07-26       Impact factor: 6.937

Review 7.  G4-associated human diseases.

Authors:  Nancy Maizels
Journal:  EMBO Rep       Date:  2015-07-06       Impact factor: 8.807

8.  Characterization of intermediate-sized insertions using whole-genome sequencing data and analysis of their functional impact on gene expression.

Authors:  Saeideh Ashouri; Jing Hao Wong; Hidewaki Nakagawa; Mihoko Shimada; Katsushi Tokunaga; Akihiro Fujimoto
Journal:  Hum Genet       Date:  2021-05-12       Impact factor: 4.132

9.  Identifying high-confidence capture Hi-C interactions using CHiCANE.

Authors:  Erle M Holgersen; Andrea Gillespie; Olivia C Leavy; Joseph S Baxter; Alisa Zvereva; Gareth Muirhead; Nichola Johnson; Orsolya Sipos; Nicola H Dryden; Laura R Broome; Yi Chen; Igor Kozin; Frank Dudbridge; Olivia Fletcher; Syed Haider
Journal:  Nat Protoc       Date:  2021-04-09       Impact factor: 13.491

Review 10.  DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability.

Authors:  Nathan Donley; Mathew J Thayer
Journal:  Semin Cancer Biol       Date:  2013-01-14       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.